http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102393279-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2017-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102393279-B1 |
| titleOfInvention | TLR7 agonist maleate salts, crystalline forms C, D and E thereof, methods for preparing maleate salts and crystalline forms and uses |
| abstract | The present invention relates to a maleate salt of a compound represented by the formula (I), a process for the preparation of the salt, a pharmaceutical composition containing the salt, and the use of the salt. The present invention also relates to crystalline forms C, D and E of the maleate salt of a compound represented by formula (I), methods for preparing said crystalline forms, crystalline and pharmaceutical compositions containing said crystalline forms, and uses thereof. |
| priorityDate | 2016-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.